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INTRODUCTION
Chronic granulomatous disease (CGD, OMIM No. 306400)
is a disorder of phagocytes due to the defective activity of
nicotinamide adenine dinucleotide phosphate (NADPH) oxi-
dase that catalyzes the production of antimicrobial superox-
ide. CGD is caused by mutations in any of 4 structural com-
ponents of this enzyme, including gp91-phox, p22-phox, p47-
phox and p67-phox. CGD is inherited either in an X-linked
or autosomal recessive manner. However, X-linked CGD is
far more common, accounting for about 70% of all CGD cases
(1, 2). The X-linked CGD gene, CYBB (GenBank Accession
No. AF469757-AF469769), is localized on chromosome
Xp21.1, spans 30 kb and contains 13 exons. Over 300 CYBB
mutations have been found along the whole gene and regis-
tered in an internationally maintained X-linked CGD database
(3). This study aimed to investigate the molecular character-
ization of 5 unrelated Korean patients with X-linked CGD.
Mutations in these patients were screened initially by single
strand conformation polymorphism (SSCP) and then con-
firmed by selective DNA sequencing of the abnormal bands.
MATERIALS AND METHODS
Activated NBT slide test
Nitroblue tetrazolium (NBT) slide test with phorbol myris-
tate acetate (PMA) was performed on the neutrophils of the
5 patients and their mothers. We considered a patient to have
X-linked CGD when the patient showed no formazan cells
while his mother showed mosaic pattern (4).
PCR-SSCP, sequencing and RT-PCR
Polymerase chain reaction (PCR) and single-strand confor-
mation polymorphism (SSCP) was done as previously describ-
ed (5, 6). A few of the previously described primers sequences
are slightly modified. Sequencing reaction was done using
Model Prism 377 (Applied Biosystems Inc., CA, U.S.A.) and
ABI Prism Dye Terminator cycle Sequencing Ready Reaction
Kit (Perkin-Elmer, CA, U.S.A.). In case of splice-site muta-
tion, CYBB gene mRNA was reversely transcribed and ampli-
fied into three overlapping fragments using three sets of syn-
thetic primers described by Dinauer et al. (7). 
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Molecular Analysis of X-linked Chronic Granulomatous Disease in
Five Unrelated Korean Patients
Chronic granulomatous disease (CGD) is a fatal genetic disorder in which phago-
cytes fail to produce antimicrobial superoxide because of NADPH oxidase deficiency.
Molecular defects in CYBB gene causing X-linked CGD are responsible for about
70% of all cases. This study was done to confirm genetic defects of CYBB gene in
five Korean patients who were highly suggestive of having CGD by clinical history.
We performed initial screening for five unrelated Korean patients using single strand
conformation polymorphism (SSCP) and then selective sequencing for the regions
involving the abnormal bands. Activated NBT tests revealed that all patients were
X-linked. SSCP analysis for CYBB gene showed abnormal bands in all patients.
The molecular defects of five patients were as follows: c.1663insT, c.1111-1G>T,
c.39_40insG, c.927delC and c.434T>C mutation. This result will help the families
with prenatal diagnosis or genetic counseling.
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Patients 
A total of five Korean unrelated patients were included in
this study. Patient 1 had suffered from recurrent anal abscesses
and inguinal lymphadenopathy from the age of 4 months to
his death at the age of two. Many bacteria were isolated from
anal pus, including Enterobacter cloacae, Klebsiellla pneumoniae,
Escherichia coli, Enterococcus faecium, and Enterobacter asburiae. He
was finally hospitalized for inguinal lymphadenopathy and
developed pneumonia, sepsis, disseminated intravascular coag-
ulation, acute renal failure, and hepatitis. He died of septic
shock. Burkholderi cepacia was isolated from blood at his death.
Patient 2 was a 12-yr-old boy who had suffered from many
infectious diseases since 2 months after birth, including recur-
rent subcutaneous abscesses caused by K. pneumoniae, Enterobac-
ter aerogenes, and Serratia marcescens, enteric fever by group B
Salmonella spp., pneumonia by Haemophilus influenzae and
Staphylococcus aureus, liver abscess by S. aureus. He had also
suffered lymphadenopathy, osteomyelitis, otitis media (the
causative microorganisms were not isolated), and Guillain-
Barre syndrome. There had been bacteremia caused by S. epi-
dermidis and bacteriuria by E. coli. 
Patient 3 was a 22-yr-old man who had suffered from tuber-
culosis, lymphadenitis, hepatitis, enteric fever, meningitis, and
Behcet’s disease since he was 6 yr old. The following bacterial
species were isolated: group B Salmonella spp. in his blood,
liver biopsy and stool; coagulase negative Staphylococcus in
bile; and Enterococcus in urine. 
Patient 4 had suffered from recurrent lymphadenitis since
six years old and suffered salmonellosis at seven. He was treated
with IFN- . When he was ten years old, he was hospitalized
for an intractable cough and rhinorrhea and aggravated to
pneumonia with pleural effusion, hepatitis, acute renal failure,
and died of septic shock. B. cepacia was isolated from his blood.
Patient 5 was a six-year-old boy who had suffered from
upper respiratory infection, lymphadenitis and liver abscesses
since four years old. No bacterial organism had been isolated.
He was in good health at the time of this study. 
RESULTS
Diagnosis of CGD patients
Activated NBT slide tests showed no respiratory burst in
all patients except patient 5 who showed microgranular pat-
tern (Table 1). The cells of the mothers of patients showed a
mosaic pattern. These findings are compatible with an X-
linked defect in these families. 
Genetic analysis of CGD patients 
Because the defect in these patients was considered X-linked,
we searched for mutations in CYBB gene. Abnormal bands by
NBT, nitroblue tetrazolium; SSCP, single strand conformation polymorphism.
Patients Mutation type
Exon showing abnormal 
SSCP pattern
Nucleotide
change
Amino acid
change
Activated NBT (%)
Patient Patient’s mother
1 insertion 0 50 exon 13 c.1663insT p.Glu555X
2 splice/deletion 0 57 exon 11 c.1111-1G>T c.1111_1784del
3 insertion 0 67 exon 1 c.39_40insG (novel) frameshift
4 deletion 0 22 exon 9 c.927delC (novel) frameshift
5 missense 100% microgranular 50% normogranular, exon 5 c.434T>C(novel) p.Leu141 Pro
50% microgranular
Table 1. The results of functional and molecular analysis for five Korean X-linked CGD patients
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Fig. 1. (A) Compared with control (lane 1, 3, 4), SSCP analysis of patient 1 showed different migration pattern around exon 13 (lane 2), (B)
The DNA sequence around exon 13 showed c.1663insT forming a premature TGA stop codon in patient 1. 
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SSCP were found in all patients from exon 13, 11, 1, 9, and
5, respectively. Five patients were confirmed to have molecular
defects in CYBB gene by selective sequencing of the regions
(Table 1). The molecular defects in 5 patients were as follows:
c.1663insT (Fig. 1), c.1111-1G>T (Fig. 2), c.39_40insG,
c.927delC and c.434T>C mutation (Fig. 3). 
DISCUSSION
This paper reports the biochemical and molecular analysis
of five unrelated Koreans with X-linked CGD. Biochemical
analysis demonstrated severe defects in the respiratory burst
of these patients except in patient 5. Even though it has been
reported that there is no clear correlation between the biochem-
ical or molecular characteristics and clinical manifestations
(8), microgranular pattern shown in patient 5 seemed to be
related with less severe clinical history. Molecular findings,
however, does not seem to be correlated with clinical severity.
For example, the same kind of frameshift mutations found
in patient 1, 3, and 4 did not lead to the same mortality in
all patients. 
CGD is a fatal immunodeficiency syndrome characterized
by severe recurrent bacterial and fungal infections. These infec-
tions occur most commonly in lungs, gastrointestinal tract,
skin and the lymph nodes (9). It has been reported that pneu-
monia occurred at least 80% of the patients and abscesses in
more than 50% (2), as was the case in this study subjects. The
causative agents in our patients with pneumonia were Bur-
kholderia cepacia (patient 1 and 4), H. influenza (patient 2), S.
aureus (patient 2), Mycobaterium spp. (patient 3), which are also
known to be commonly isolated. It has been reported that
pulmonary colonization of B. cepacia can lead to a rapid and
progressive pneumonic illness termed cepacia syndrome in
some cases (10). It is noteworthy that B. cepacia was isolated in
blood samples of patient 1 and 4 at their death. Liver (Patient
1, 3, and 5), anal (Patient 1), and subcutaneous abscess (Patient
2) occurred in 4 of 5 patients. 
In patient 1, a T insertion in exon 13 was found, which led
to the formation of a TGA stop codon. This nonsense muta-
tion will result in the synthesis of truncated CYBB gene pro-
tein that will be very unstable and easily degraded. This muta-
tion has been previously reported in other CGD patient (3, 11).
The mutation found in patient 2 was a splice-site mutation.
Mutations around splice junctions are relatively common (12,
13). But c.1111-1G>T is quite rare. RT-PCR of the case
Fig. 3. Novel mutations were found, including c.39_40insG in patient 3, c.927delC in patient 4 and c.434T>C in patient 5. 
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Fig. 2. (A) The DNA sequence of patient 2 shows a c.1111-1G>T, (B) The cDNA RT-PCR reveals exon II deletion in patient 2 (lane 8). The
694 bp sized fragment included cDNA sequence from 1111 to 1784. Lane 1, 4, 7 were of a control. Lane 2, 5, 8 were of the patient. Lane
3, 6, 9 were of the patient’s mother with both normal and abnormal bands in lane 9. 
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revealed the total absence of exon 11 (sequencing result for
the cDNA is not shown here), while his mother have both
normal and abnormal bands (Fig. 2). 
In patient 3, a G insertion occurred in runs of identical G
nucleotides. This kind of mutation is considered to occur
because of slipped mispairing at the DNA replication fork,
which has been also commonly observed in CYBB (14). The
mutation of patient 3 resulted in frameshift, which might
have caused severe phenotype as in patient 1 and 4. However,
he was 22 yr old and still alive at the time of this study. It
seems to be difficult to explain why the same kind of frameshift
mutations found in patient 1, 3, and 4 did not lead to the
same mortality in all patients,
Missense mutation as shown in patient 5, leading to a single
amino acid replacement, is commonly seen in X-CGD. Our
case showed p.Leu141Pro mutation. This position is of the
N-terminal domain and considered outside of the membrane.
Mutations that occur near this site have been reported to show
an X91+phenotype, which is defined as normal expression
of the CYBB gene protein with no oxidase activity (14). Micro-
granular pattern of activated NBT, however, may indicate an
X91-phenotype (partial loss of protein expression). Further
investigation is needed to find the molecular and functional
characterization of this case. 
Carriers of X-linked CGD are usually detected by the PMA
activated NBT test as in our five unrelated families. Carrier
detection is very important because sons of a carrier have a
50% risk of inheriting the defect and becoming patients.
However, it is not an easy task to make a prenatal diagnosis
of a fetus if we rely only on the activated NBT test, because
an required amount of phagocytes can not be obtained in
the first trimester (15). Molecular genetic study should be
done both to confirm the diagnosis and to make prenatal
diagnosis easier in the family (16). If the mutation is found
in a patient and a carrier, it will be easier to find whether a
fetus has the same mutation using genomic DNA sample. 
SSCP is an appropriate screening method if mutations occur
with no hot spot along the whole gene of which size is too
long and has many exons as in CYBB gene. Although there
are limitations of finding mutations in long base pairs, SSCP
is known to exhibit a high degree of sensitivity in detecting
single nucleotide differences (17). Highly conservative sequence
of CYBB gene is also favorable aspect for SSCP analysis in
this disease. 
In summary, we identified mutations of the CYBB gene
that are responsible for X-linked CGD in 5 unrelated Kore-
an patients. Three mutations in patients 3, 4 and 5 have not
been reported yet. Initial screening by SSCP and selective
sequencing was a good strategy for mutation detection in this
disease. All the results were quite different from one another,
revealing that the molecular defects in Korean patients are
also very heterogeneous. Compared with patients of other
ethnic group, no specific frequency pattern of mutations was
found. Further study is needed to find out whether there are
more common mutations among Korean patient population.
The results of this study will be a basis for the further study of
the molecular and functional features of the NADPH oxidase
and helping the families with prenatal diagnosis or genetic
counseling. 
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